Minerva Neurosciences | NERV - EPS - Lucro por Ação





Eps Alterar Data
Acadia Pharmaceuticals USD 0.31 0.13 2026-09
Adma Biologics USD 0.16 0.03 2026-06
ALKERMES USD 0.09 0.09 2026-09
Alterity Therapeutics Limited AUD 0 0 2025-12
AstraZeneca USD 2.79 0.16 2026-09
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Bristol-Myers Squibb USD 1.35 0.69 2026-09
Cipla INR 10.85 1.09 2026-09
Clal Biotechnology ILS -0.04 0.1 2022-12
Compugen USD -0.07 0.16 2026-06
CSL USD 5.07 3 2025-12
Eli Lilly USD 7.48 0.9 2026-09
GlaxoSmithKline GBP 0.55 0.04 2026-09
Grifols EUR 0.16 0.02 2026-03
Halozyme Therapeutics USD 2.39 0.11 2026-09
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
J&J USD 2.7 0.2 2026-09
Merck USD 2.49 2.62 2026-09
Minerva Neurosciences USD -0.56 3.53 2024-12
Neurocrine Biosciences USD 3.29 0.44 2026-09
Novartis USD 2.46 0.05 2026-09
Novavax USD 0.13 0.59 2025-12
Pfizer USD 0.87 0.1 2026-09
Roche Holding CHF 10.98 2.61 2026-06
Sanofi EUR 3.55 1.46 2026-09
Takeda JPY 116.95 45.3 2026-09
Vanda Pharmaceuticals USD -0.09 0 2024-12